Status:
COMPLETED
The Rhode Island Prescription and Illicit Drug Study
Lead Sponsor:
Brown University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Overdose
Drug Overdose
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will test the efficacy of a novel drug-checking intervention to prevent fatal and non-fatal overdose among people who use drugs (PWUD), who are 18-65 years old at the time of enrollment. Th...
Detailed Description
The investigators will assess the efficacy of the RAPIDS intervention on preventing overdose among PWUD. Participants will be randomized 1:1 to receive the RAPIDS intervention or the attention-matched...
Eligibility Criteria
Inclusion
- Reside in Rhode Island
- Are able to complete interviews in English
- Are able to provide informed consent
- Self-report past 30 day heroin, illicit stimulants, counterfeit prescription pills, or injection drugs
Exclusion
- Participants who exclusively misuse medications obtained from a physician or diversion from someone else's prescription
Key Trial Info
Start Date :
August 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
509 Patients enrolled
Trial Details
Trial ID
NCT04372238
Start Date
August 31 2020
End Date
February 29 2024
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brown University School of Public Health
Providence, Rhode Island, United States, 02912